Rare Disease Drugmakers Face Pressure from Trump-Backed Laws
Despite a push by the Trump administration to slash prices, rare disease drugmakers are trying to avoid price cuts.
Synthesized news with full source attribution.
Despite a push by the Trump administration to slash prices, rare disease drugmakers are trying to avoid price cuts.